Merck & Co Inc
NYSE: MRK
$115.60
-$1.57 (-1.3%)
Closing Price on September 23, 2024
MRK Articles
The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this week are Dow Jones Industrial Average components. Merck & Co. (NYSE: MRK)...
Published:
ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted adjusted diluted earnings per share (EPS) of $0.92...
Published:
Last Updated:
courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since there is a great deal of evidence that most...
Published:
Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also be the last week of major on-calendar earnings for the third quarter, even if...
Published:
Jon OggWe have seen the short interest reports for the October 15 settlement date. It turns out that short sellers have been getting out of the way of the bull market after previously increasing...
Published:
Courtesy Boeing Co.The Merrill Lynch Technical Titans List was formerly known as the Most Attractive Buy List and was introduced in February 2006. It is designed to identify common stocks that are...
Published:
ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can be treated does....
Published:
Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government shutdown and the debt ceiling. So which are the stocks to buy and which the stocks to...
Published:
ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual funds. The end-of-September short interest saw...
Published:
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks....
Published:
Jon OggInvestors and traders alike are stuck trying to determine what to do with their stocks during a government shutdown and ahead of the debt ceiling debate. Each morning 24/7 Wall St. reviews...
Published:
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research...
Published:
ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over 80 companies in the index do not pay dividends. Paying dividends has become...
Published:
Last Updated:
ThinkstockDrugmaker Merck & Co. Inc. (NYSE: MRK) announced Tuesday morning that it will fire another 8,500 employees in an effort to “sharpen” the company’s focus on R&D and returns to...
Published:
Last Updated:
ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual funds. In fact, the mid-September short interest...
Published: